These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30363747)

  • 1. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry.
    Sigal SH; Amin A; Chiodo JA; Sanyal A
    Can J Gastroenterol Hepatol; 2018; 2018():1579508. PubMed ID: 30363747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry).
    Dunlap ME; Hauptman PJ; Amin AN; Chase SL; Chiodo JA; Chiong JR; Dasta JF
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment practice and outcomes. Report of the hyponatremia registry.
    Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
    Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
    Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
    Dasta JF; Sundar S; Chase S; Lingohr-Smith M; Lin J
    Hosp Pract (1995); 2018 Oct; 46(4):197-202. PubMed ID: 30045645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
    Burst V; Grundmann F; Kubacki T; Greenberg A; Rudolf D; Salahudeen A; Verbalis J; Grohé C
    Support Care Cancer; 2017 Jul; 25(7):2275-2283. PubMed ID: 28255808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
    Cárdenas A; Ginès P; Marotta P; Czerwiec F; Oyuang J; Guevara M; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):571-8. PubMed ID: 22027579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
    Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
    Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
    Amin AN; Ortendahl JD; Harmon AL; Kamat SA; Stellhorn RA; Chase SL; Sundar SV
    Curr Med Res Opin; 2018 Mar; 34(3):559-566. PubMed ID: 29297709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.
    Gheorghiade M; Gottlieb SS; Udelson JE; Konstam MA; Czerwiec F; Ouyang J; Orlandi C;
    Am J Cardiol; 2006 Apr; 97(7):1064-7. PubMed ID: 16563917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure.
    Cyr PL; Slawsky KA; Olchanski N; Krasa HB; Goss TF; Zimmer C; Hauptman PJ
    Am J Health Syst Pharm; 2011 Feb; 68(4):328-33. PubMed ID: 21289328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.
    Wang S; Zhang X; Han T; Xie W; Li Y; Ma H; Liebe R; Weng H; Ding HG
    BMC Gastroenterol; 2018 Sep; 18(1):137. PubMed ID: 30180806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
    Schrier RW; Gross P; Gheorghiade M; Berl T; Verbalis JG; Czerwiec FS; Orlandi C;
    N Engl J Med; 2006 Nov; 355(20):2099-112. PubMed ID: 17105757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C; Hutchinson DJ
    Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hyponatremia in Patients with Acute Neurological Injury.
    Human T; Cook AM; Anger B; Bledsoe K; Castle A; Deen D; Gibbs H; Lesch C; Liang N; McAllen K; Morrison C; Parker D; Rowe AS; Rhoney D; Sangha K; Santayana E; Taylor S; Tesoro E; Brophy G
    Neurocrit Care; 2017 Oct; 27(2):242-248. PubMed ID: 28054290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatremia: a problem-solving approach to clinical cases.
    Assadi F
    J Nephrol; 2012; 25(4):473-80. PubMed ID: 22307436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrolytes: Sodium Disorders.
    Braun MM; Mahowald M
    FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Hyponatremia and Its Associated Morbimortality in Hospitalized Patients Receiving Parenteral Nutrition.
    Gómez-Hoyos E; Cuesta M; Del Prado-González N; Matía P; Pérez-Ferre N; De Luis DA; Calle-Pascual A; Rubio MÁ; Runkle-De la Vega I
    Ann Nutr Metab; 2017; 71(1-2):1-7. PubMed ID: 28618404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.